Table 1.
Model input | |||
---|---|---|---|
Parameter | 18-64 y | ≥65 y | Source |
Base case analysis | |||
US male population in 2022, No. | 101,599,370 | 26,727,557 | US Census Bureau20 |
Average mortality rates, % | 0.4 | 13.4 | Centers for Disease Control and Prevention40 |
US insured population, % | 88.1 | 99.0 | US Census Bureau21 |
US insured population with ED diagnosis, % | 10.0 | 6.2 | Administrative claims data analysis |
Diagnosed population not receiving any ED treatment paid for by primary insurance, % | 94.0 | 99.5 | Administrative claims data analysis |
US male population with moderate to severe ED, % | 18.2 | Rhoden et al24 | |
US male population with any contraindications for penile prosthesis implantation, % | 1.0 | Assumption based on US penile prosthesis manufacturer instruction for use25,26 and American Urological Association guideline10 contraindications of treatable/transient infections |
Abbreviation: ED, erectile dysfunction.